AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 276 filers reported holding AVANOS MED INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340,960 | +17.1% | 16,865 | +48.0% | 0.00% | 0.0% |
| Q2 2023 | $291,151 | -7.0% | 11,393 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $312,918 | +29.1% | 10,523 | +17.1% | 0.00% | – |
| Q4 2022 | $242,399 | +59.5% | 8,984 | +28.6% | 0.00% | – |
| Q3 2022 | $152,000 | -30.3% | 6,985 | -12.7% | 0.00% | – |
| Q2 2022 | $218,000 | -74.6% | 8,003 | -69.2% | 0.00% | -100.0% |
| Q1 2022 | $859,000 | +209.0% | 26,025 | +224.7% | 0.00% | +100.0% |
| Q4 2021 | $278,000 | +36.9% | 8,014 | +23.5% | 0.00% | – |
| Q3 2021 | $203,000 | +35.3% | 6,491 | +58.1% | 0.00% | – |
| Q2 2021 | $150,000 | -18.0% | 4,105 | -2.1% | 0.00% | – |
| Q1 2021 | $183,000 | -9.9% | 4,194 | -6.0% | 0.00% | -100.0% |
| Q4 2020 | $203,000 | +26.9% | 4,464 | -7.3% | 0.00% | – |
| Q3 2020 | $160,000 | -12.1% | 4,814 | -22.4% | 0.00% | -100.0% |
| Q2 2020 | $182,000 | +34.8% | 6,203 | -92.7% | 0.00% | 0.0% |
| Q1 2020 | $135,000 | – | 85,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 1,991,583 | $86,853,000 | 6.59% |
| Palmer Knight Co | 82,642 | $3,604,000 | 3.11% |
| RGM Capital, LLC | 751,523 | $32,774,000 | 2.36% |
| Sandhill Capital Partners LLC | 397,462 | $17,333,000 | 2.20% |
| BROADVIEW ADVISORS LLC | 123,838 | $5,401,000 | 1.67% |
| MOODY ALDRICH PARTNERS LLC | 93,736 | $4,088,000 | 1.04% |
| Champlain Investment Partners, LLC | 2,455,532 | $107,086,000 | 0.90% |
| Krensavage Asset Management, LLC | 59,378 | $2,589,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 444,973 | $19,405,000 | 0.64% |
| PURA VIDA INVESTMENTS, LLC | 85,000 | $3,707,000 | 0.56% |